AML1-ETO is a transcriptional regulator whose genome-wide direct binding targets have been extensively mapped in human t(8;21) AML cell lines30, 31, 32, 33 and are known to overlap with binding targets of wild-type RUNX1 (refs 33, 34). Here, RUNX1 is linked to acute myeloid leukemia.